Microbiologia/Virologia
Os inibidores de microbiologia e virologia são compostos que têm como alvo microrganismos, incluindo bactérias, vírus e fungos, interrompendo seu crescimento, replicação ou sobrevivência. Esses inibidores são essenciais para estudar a patogênese microbiana, entender os mecanismos de resistência e desenvolver novas terapias antimicrobianas e antivirais. Os inibidores nessa categoria são usados para combater doenças infecciosas, explorar a ecologia microbiana e investigar as interações hospedeiro-patógeno. Na CymitQuimica, oferecemos uma ampla seleção de inibidores de alta qualidade para microbiologia e virologia para apoiar sua pesquisa em doenças infecciosas, microbiologia e virologia.
Subcategorias de "Microbiologia/Virologia"
- Antibacteriano(2.968 produtos)
- Antibiótico(922 produtos)
- Antifecção(23 produtos)
- DHFR(33 produtos)
- Síntese de DNA/RNA(711 produtos)
- HBV(177 produtos)
- HIV Protease(451 produtos)
- HSV(91 produtos)
- Integrase(2 produtos)
- Ribossomo(13 produtos)
Exibir 2 mais subcategorias
Foram encontrados 5863 produtos de "Microbiologia/Virologia"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
FR-182024
CAS:<p>FR-182024 is a novel cephem derivative, it has potent anti-Helicobacter pylori activity.</p>Fórmula:C18H16N4O4S3Cor e Forma:SolidPeso molecular:448.54Dealanylalahopcin
CAS:<p>Dealanylalahopcin is a procollagen prolyl-4-hydroxylase inhibitor.</p>Fórmula:C6H10N2O5Cor e Forma:SolidPeso molecular:190.15Purfalcamine
CAS:<p>Purfalcamine, a selective PfCDPK1 inhibitor effective against malaria, has IC50 of 17 nM and EC50 of 230 nM; halts parasites at schizont stage.</p>Fórmula:C29H33FN8OCor e Forma:SolidPeso molecular:528.62(-)-Pinocembrin
CAS:<p>(-)-Pinocembrin: Anti-tuberculosis (IC50: 1.11 mg/mL dormant, 1.21 mg/mL active), antiproliferative (IC50: 1.88-11 mg/mL on various cell lines).</p>Fórmula:C15H12O4Cor e Forma:SolidPeso molecular:256.25Antileishmanial agent-3
CAS:<p>Antileishmanial agent-3 (Compound 13) effectively inhibits the growth of Leishmania major [1].</p>Fórmula:C14H13ClN6O4Cor e Forma:SolidPeso molecular:364.74RO5464466
CAS:<p>RO5464466 is an inhibitor of influenza A virus (H1N1) fusion.</p>Fórmula:C16H26N2O3SCor e Forma:SolidPeso molecular:326.45(5S,8R)-HBV-IN-10
CAS:<p>'(5S,8R)-HBV-IN-10 is an EC50 0.1-1 μM HBsAg inhibitor, isomer of compound 6 from patent WO2021204258A1.</p>Fórmula:C23H24FN7OCor e Forma:SolidPeso molecular:433.48Efavirenz, (R)-
CAS:<p>Efavirenz, (R)- is an antiviral agent and a nonnucleoside HIV-1 reverse transcriptase inhibitor.</p>Fórmula:C14H9ClF3NO2Cor e Forma:SolidPeso molecular:315.67Antibacterial agent 19
CAS:<p>Antibacterial agent 19 targets K. pneumoniae and multi-resistant S. aureus with MICs: 0.022 and 0.045 mg/mL.</p>Fórmula:C16H16F2N2O4Cor e Forma:SolidPeso molecular:338.31HSV-1/HSV-2-IN-1
CAS:<p>HSV-1/HSV-2-IN-1 inhibits HSV-1, HSV-2, and cowpox virus with EC50 values of 7.6, 7.6, 4, and 12 μM, respectively.</p>Fórmula:C18H14F4N4OSCor e Forma:SolidPeso molecular:410.39Antistaphylococcal agent 1
CAS:<p>Antistaphylococcal agent 1 is an antistaphylococcal therapeutic agent.</p>Fórmula:C22H16N6O2Cor e Forma:SolidPeso molecular:396.4Mtb-cyt-bd oxidase-IN-3
<p>Mtb-cyt-bd oxidase-IN-3 inhibits M. tuberculosis growth, IC50 0.36 μM, MIC 32 μM, for TB research.</p>Fórmula:C26H35NO2Cor e Forma:SolidPeso molecular:393.56Enisamium iodide
CAS:<p>Enisamium iodide is used as an antiviral agent.</p>Fórmula:C14H15IN2OCor e Forma:SolidPeso molecular:354.19Antiviral agent 19
CAS:<p>Antiviral agent 19 (Compound 3) is a selective inhibitor of Zika virus (EC50: 1.3 μM) with low cytotoxicity.</p>Fórmula:C29H35NO5Cor e Forma:SolidPeso molecular:477.59Antibacterial agent 95
CAS:<p>Antibacterial 95, a quinoline-derived antituberculotic, shows 0.3 μM MIC against Mycobacterium tuberculosis H37Rv and inhibits its growth in macrophages.</p>Fórmula:C19H16ClNO3Cor e Forma:SolidPeso molecular:341.79Antibacterial agent 64
CAS:<p>Potent antibacterial, YycG inhibitor with 6.1 µM IC50. Synergistic with ampicillin against biofilm bacteria.</p>Fórmula:C29H20ClN3O6S2Cor e Forma:SolidPeso molecular:606.07Antibacterial agent 74
CAS:<p>Antibacterial agent 74 (compound 36) has anti-Salmonella activity [1].</p>Fórmula:C16H20N2O3Cor e Forma:SolidPeso molecular:288.34Vebufloxacin
CAS:<p>Vebufloxacin (OPC-7251) shows potent antibacterial activity against gram-positive and -negative bacteria, including Staphylococcus aureus and Pseudomonas</p>Fórmula:C19H22FN3O3Pureza:98%Cor e Forma:SolidPeso molecular:359.39HIV-1 inhibitor-31
CAS:<p>HIV-1 inhibitor-31 (compound 4) is a potent inhibitor of HIV-1. HIV-1 inhibitor-31 can be used in the study of AIDS.</p>Fórmula:C21H13Cl2N3O2Cor e Forma:SolidPeso molecular:410.25GW-695634
CAS:<p>GW-695634, a non-nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Fórmula:C26H21Cl2N3O6SCor e Forma:SolidPeso molecular:574.43PqsR/LasR-IN-3
CAS:<p>PqsR/LasR-IN-3 (Compound 7a) inhibits hERG with the IC 50 of 109.01 μM which is also a PqsR and LasR systems inhibitor in P. aeruginosa [1].</p>Fórmula:C14H17NO5SCor e Forma:SolidPeso molecular:311.35Antibacterial agent 105
CAS:<p>Compound 17, a phenanthrolinic quinolone, fights M. tuberculosis (MIC 90: 2.64 μM) and various bacteria (MIC 90: 0.70-44.70 μM).</p>Fórmula:C14H9N3O5Cor e Forma:SolidPeso molecular:299.24Influenza virus-IN-4
CAS:<p>Influenza virus-IN-4 (compound 11e) is a potent inhibitor of influenza virus neuraminidase, acting on H5N1 (IC50: 3.4 μM), H5N2 (IC50: 0.094 μM), H5N6 (IC50: 0.</p>Fórmula:C23H31FN2O4Cor e Forma:SolidPeso molecular:418.5Acyclovir monophosphate
CAS:<p>Acyclovir monophosphate, a strong anti-HSV agent, inhibits viral DNA polymerase, blocking DNA synthesis and chain elongation.</p>Fórmula:C8H12N5O6PCor e Forma:SolidPeso molecular:305.18Antibacterial agent 104
CAS:<p>Antibacterial agent 104 is an effective antibacterial agent with significant antibacterial effects in vitro and good anti-MRSA effects in vivo.</p>Fórmula:C28H39NO4SCor e Forma:SolidPeso molecular:485.68P163-0892
CAS:<p>P163-0892: potent, specific antifungal for Cryptococcus; moderate blood-brain barrier penetration.</p>Fórmula:C19H20N2O3SCor e Forma:SolidPeso molecular:356.44LpxC-IN-9
CAS:<p>LpxC-IN-9 (compound 19) is a potent inhibitor of LpxC and exhibits antibacterial and hypotensive activity.</p>Fórmula:C23H25N5O3SCor e Forma:SolidPeso molecular:451.54Aranotin
CAS:<p>Aranotin, from Arachniotus aureus, inhibits RNA viruses by blocking RNA polymerase.</p>Fórmula:C20H18N2O7S2Cor e Forma:SolidPeso molecular:462.5Mycobacterial Zmp1-IN-1
<p>Zmp1-IN-1: An inhibitor of mycobacterial Zmp1 with dose-dependent anti-tuberculosis effects.</p>Fórmula:C26H27N3O7SCor e Forma:SolidPeso molecular:525.57Fungicide4
CAS:<p>Fungicide4 exhibits the high activity against the P. infestans strain.</p>Fórmula:C14H11N3OCor e Forma:SolidPeso molecular:237.26SARS-CoV-2-IN-15
CAS:<p>SARS-CoV-2-IN-15, a stable niclosamide analogue, enhances bioavailability and half-life, with potent antiviral activity (IC50: 0.49 μM).</p>Fórmula:C14H9ClF3NO2Cor e Forma:SolidPeso molecular:315.67Mt KARI-IN-2
CAS:<p>Mt KARI-IN-2, an inhibitor for Mtb KARI (Ki: 2.02 μM) and Mtb H37Rv (MIC: 0.78 μM), has low cytotoxicity (HEK IC50: >86 μg/mL).</p>Fórmula:C14H11N5O4S2Cor e Forma:SolidPeso molecular:377.4DprE1-IN-4
CAS:<p>DprE1-IN-4: Potent DprE1 inhibitor (IC50: 0.90 μg/mL), good pharmacokinetics, kills TB bacteria in mice.</p>Fórmula:C20H21N3O5SCor e Forma:SolidPeso molecular:415.46gp120-IN-2
CAS:<p>gp120-IN-2 is a potent HIV-1 inhibitor (IC50 = 7.5 μM) with low cytotoxicity (CC50 = 112.93 μM).</p>Fórmula:C15H18N2O5Cor e Forma:SolidPeso molecular:306.31OYYF-175
CAS:<p>OYYF-175: potent antimicrobial antifolate; targets multi-drug resistant Gram-Negative bacteria; DHFR inhibitor with 2.36 nM IC50 against E. coli.</p>Fórmula:C17H14FN5Cor e Forma:SolidPeso molecular:307.33HCV-IN-36
CAS:<p>HCV-IN-36: oral HCV inhibitor, EC50 0.016 μM, CC50 8.78 μM, potent antiviral.</p>Fórmula:C30H36ClN5Cor e Forma:SolidPeso molecular:502.09DHQZ 36
CAS:<p>DHQZ 36: retrograde trafficking inhibitor, anti-parasite, stops Leishmania amazonensis (EC50: 13.63 μM).</p>Fórmula:C21H18F2N2OSPureza:98%Cor e Forma:SolidPeso molecular:384.44Soporidine
CAS:<p>Soporidine, a strigolactone antagonist, blocks AtHTL, hindering SL signaling and seed germination.</p>Fórmula:C27H30F3NO3Pureza:98%Cor e Forma:SolidPeso molecular:473.53GRL-0820
CAS:GRL-0820 is a SARS-CoV-2 Protease inhibitor (IC50 = 73 nM). GRL-0820 blocked SARS-CoV-2 infection but viral breakthrough occurred.Fórmula:C17H13ClN2O2Pureza:98.27%Cor e Forma:SolidPeso molecular:312.75CL-55
CAS:<p>CL-55 is a novel inhibitor of T3SS.</p>Fórmula:C19H17F2N3O4SCor e Forma:SolidPeso molecular:421.42SARS-CoV-2 3CLpro-IN-7
CAS:<p>SARS-CoV-2 3CLpro-IN-7 is a reversible covalent inhibitor of the SARS-CoV-2 3CL protease, exhibiting an inhibitory concentration (IC50) value of 1.4 µM.</p>Fórmula:C24H17ClN2O6Cor e Forma:SolidPeso molecular:464.85Antimalarial agent 11
CAS:<p>Antimalarial compound 1: Spirocyclic chromane, EC50 - D6: 1.48 μM, ARC08-022: 1.81 μM.</p>Fórmula:C25H25F2NO3Cor e Forma:SolidPeso molecular:425.47DLC27-14
CAS:<p>DLC27-14 is an HIV-1 Nef specific protein disorder catalyzer.</p>Fórmula:C25H25NO4Cor e Forma:SolidPeso molecular:403.47Sitamaquine tosylate
CAS:<p>Sitamaquine: antileishmanial, targets L. donovani species, EC50 = 9.5-19.8 μM, inhibits mitochondrial complex II, induces apoptosis in promastigotes.</p>Fórmula:C28H41N3O4SCor e Forma:SolidPeso molecular:515.71Cadrofloxacin
CAS:<p>Cadrofloxacin (Caderofloxacin, CS-940) is a novel fluoroquinolone antimicrobial agent.</p>Fórmula:C19H20F3N3O4Cor e Forma:SolidPeso molecular:411.38Neuraminidase-IN-8
CAS:<p>Neuraminidase-IN-8 (Compound 6d) is a powerful inhibitor of neuraminidase, exhibiting a low half-maximal inhibitory concentration (IC50) of 0.027 μM and</p>Fórmula:C18H16FN3O3SCor e Forma:SolidPeso molecular:373.4Neuraminidase-IN-3
CAS:<p>Neuraminidase-IN-3 inhibits flu NA: H1N1 IC50=0.73nM, H5N1=0.26nM, H5N8=0.63nM.</p>Fórmula:C27H32N2O4SCor e Forma:SolidPeso molecular:480.62Afabicin disodium
CAS:<p>Afabicin (Debio 1450), a Debio1452 precursor, targets Staphylococcus by inhibiting lipid synthesis.</p>Fórmula:C23H22N3Na2O7PCor e Forma:SolidPeso molecular:529.396Metallo-β-lactamase-IN-2
CAS:<p>Metallo-β-lactamase-IN-4 (compound 40) is a potent metallo-β-lactamases (MBL) inhibitor with IC 50 values of 0.1 μM for VIM-1, 1.3 μM for NDM-1 and 5.0 μM for</p>Fórmula:C9H9Cl2NOSCor e Forma:SolidPeso molecular:250.14Antibacterial agent 122
CAS:<p>Thiourea derivative 122 is a low-toxicity antibacterial used in tuberculosis research with anti-mycobacterial properties.</p>Fórmula:C15H14N2O3SCor e Forma:SolidPeso molecular:302.35EP39
<p>EP39 is a potent HIV-1 inhibitor, stabilizing the SP1 domain's helix and blocking virus maturation.</p>Fórmula:C38H62N2O5Cor e Forma:SolidPeso molecular:626.91HBV-IN-6
CAS:<p>HBV-IN-6 is a potent inhibitor of HBV (EC50: 44 nM).</p>Fórmula:C23H21ClFN3O5S2Cor e Forma:SolidPeso molecular:538.01Posaconazole hydrate
CAS:<p>Posaconazole: broad-spectrum antifungal, second-gen triazole, strong C14α demethylase inhibitor (IC50: 0.25 nM).</p>Fórmula:C37H44F2N8O5Pureza:98%Cor e Forma:SolidPeso molecular:718.79Metallo-β-lactamase-IN-3
CAS:<p>Metallo-β-lactamase-IN-3 (compound 35) is a potent metallo-β-lactamases (MBL) inhibitor that has the potential to restore the activity of current β-lactam</p>Fórmula:C10H11NO3SCor e Forma:SolidPeso molecular:225.26Antitrypanosomal agent 10
<p>Antitrypanosomal agent 10, an antitrypanosomal compound, effectively inhibits Trypanosoma cruzi with an IC50 of 0.28 μM.</p>Fórmula:C17H9F6N5OCor e Forma:SolidPeso molecular:413.28Influenza A virus-IN-4
CAS:<p>Influenza A virus-IN-4 (23b), a potent neuraminidase inhibitor derived from Oseltamivir, effectively targets influenza viruses.</p>Fórmula:C19H28N4O4Cor e Forma:SolidPeso molecular:376.45Derquantel
CAS:<p>nicotinic acetylcholine receptor antagonist</p>Fórmula:C28H37N3O4Pureza:98%Cor e Forma:SolidPeso molecular:479.61Silthiofam
CAS:<p>Silthiofam effectively combats Ggt, a wheat take-all fungus, now widely used for control in China.</p>Fórmula:C13H21NOSSiPureza:98%Cor e Forma:SolidPeso molecular:267.46FtsZ-IN-2
CAS:<p>FtsZ-IN-2, a bacterial FtsZ inhibitor, hampers GTPase; has anti-MRSA/MSSA effects with 2 μg/ml MIC.</p>Fórmula:C30H35N5SCor e Forma:SolidPeso molecular:497.7Mtb-cyt-bd oxidase-IN-6
CAS:<p>Mtb-cyt-bd oxidase-IN-6, a potent inhibitor of Mycobacterium tuberculosis (Mtb) cytochrome bd (cyt-bd) oxidase (MtbCyt-bd Oxidase), exhibits an inhibitory</p>Fórmula:C20H27NOCor e Forma:SolidPeso molecular:297.43FLDP-5
CAS:<p>FLDP-5: BBB-penetrant curcuminoid, induces ROS, DNA damage, S phase arrest, suppresses tumors in LN-18 cells.</p>Fórmula:C21H21NO5Cor e Forma:SolidPeso molecular:367.4Metallo-β-lactamase-IN-4
CAS:<p>Metallo-β-lactamase-IN-4 (compound 40) is a potent inhibitor of metallo-β-lactamases (MBL) with IC 50 values of 0.5 μM, 2.1 μM, and 3.3 μM for VIM-1, NDM-1 and</p>Fórmula:C10H14N4O3S2Cor e Forma:SolidPeso molecular:302.37SJ-3366
CAS:<p>SJ3366 is a unique and highly potent nonnucleoside reverse transcriptase human immunodeficiency virus type 1 and HIV-2 inhibitor.</p>Fórmula:C21H24N2O3Cor e Forma:SolidPeso molecular:352.43Floxacrine
CAS:<p>Floxacrine is drug candidate for chemoprophylaxis of malaria.</p>Fórmula:C20H13ClF3NO3Pureza:98%Cor e Forma:SolidPeso molecular:407.77BK 218
CAS:<p>BK 218: New cephalosporin, treats S. pneumoniae, H. influenzae, M. catarrhalis; less effective on penicillin-resistant strains; oral/IV use.</p>Fórmula:C15H14ClN7NaO5S2Cor e Forma:SolidPeso molecular:494.88Phenosulfazole
CAS:<p>Phenosulfazole is a potent antiviral agent which has the potential for the research of poliomyelitis virus [1].</p>Fórmula:C9H8N2O3S2Cor e Forma:SolidPeso molecular:256.3HIV-1 inhibitor-37
CAS:<p>HIV-1 inhibitor-37, a potent HIV-1 suppressant, shows promise as a novel latent reactivator.</p>Fórmula:C14H11Cl3N4OCor e Forma:SolidPeso molecular:357.62MptpB-IN-1
CAS:<p>MptpB-IN-1: orally active, potent MptpB inhibitor; reduces drug-resistant tuberculosis.</p>Fórmula:C17H11Cl2NO4Cor e Forma:SolidPeso molecular:364.18Werner syndrome RecQ helicase-IN-3
CAS:<p>Potent WRN inhibitor, Werner syndrome RecQ helicase-IN-3, is orally active with 0.06 µM IC50; exhibits antiproliferative and anticancer effects.</p>Fórmula:C31H30ClF3N8O5Cor e Forma:SolidPeso molecular:687.07EV-A71-IN-1
CAS:<p>EV-A71-IN-1: potent EV-A71 capsid inhibitor, EC50 0.27 μM, disrupts VP1/hSCARB2 interaction, broad-spectrum antiviral, non-toxic to human cells.</p>Fórmula:C21H15N5SCor e Forma:SolidPeso molecular:369.44F8-S40
CAS:<p>F8-S40 is a SARS-CoV-2 main protease inhibitor (IC 50 = 10.88 μM) [1].</p>Fórmula:C13H11N3O3SCor e Forma:SolidPeso molecular:289.31Marasmic acid
CAS:<p>Marasmic acid is a bioactive antifungal.</p>Fórmula:C15H18O4Cor e Forma:SolidPeso molecular:262.3Hexamide
CAS:<p>Hexamide is a protein inhibitor.</p>Fórmula:C13H17NOCor e Forma:SolidPeso molecular:203.28Antitubercular agent 34
CAS:<p>Compound 42g: potent antitubercular, MIC 90 of 1.25 µg/mL, resists liver metabolism.</p>Fórmula:C19H14N4O2SCor e Forma:SolidPeso molecular:362.41Sudoterb HCl
CAS:<p>Sudoterb has anti-tubercular activity.</p>Fórmula:C29H30Cl2F3N5OPureza:98%Cor e Forma:SolidPeso molecular:592.48Cylindrospermopsin
CAS:<p>Cylindrospermopsin: a toxic cyanobacterial uracil derivative, disrupts protein/glutathione synthesis in hepatocytes, and is genotoxic.</p>Fórmula:C15H21N5O7SCor e Forma:SolidPeso molecular:415.42SARS-CoV-2-IN-36
<p>SARS-CoV-2-IN-36: strong Mpro inhibitor, IC50=2.37μM, Kd=1.19μM, fights UC-1074/RG2674/NVDBB-2220 variants.</p>Fórmula:C17H21N5O3Cor e Forma:SolidPeso molecular:343.38MMT5-14
CAS:<p>MMT5-14: potent SARS-CoV-2 inhibitor, improves antiviral activity (2-7x), boosts prodrug in plasma/lungs (200-300x), raises NTP in lungs (5x).</p>Fórmula:C39H55N6O8PCor e Forma:SolidPeso molecular:766.86HCV-IN-34
CAS:<p>HCV-IN-35, an oral HCV blocker, has an EC50 of 0.010 μM and a CC50 of 7.5 μM, indicating strong antiviral effects.</p>Fórmula:C31H36ClN5Cor e Forma:SolidPeso molecular:514.1ST7612AA1
CAS:<p>ST7612AA1: potent, oral HDAC inhibitor; reactivates HIV-1 latency; shows antitumor effects; may study malaria.</p>Fórmula:C20H27N3O4SPureza:99.71%Cor e Forma:SolidPeso molecular:405.51PknB-IN-1
CAS:<p>PknB-IN-1 inhibits PknB (IC50: 14.4 μM), has anti-mycobacterial effects (MIC: 6.2 μg/mL) against M. tuberculosis H37Rv.</p>Fórmula:C25H30N2O2Cor e Forma:SolidPeso molecular:390.52PXYD3
CAS:<p>PXYD3 inhibits RpsA-CTD (Kd: 5.66 μM) & RpsA-CTD Δ438A (Kd: 6.91 μM) crucial in Mtb translocation.</p>Fórmula:C25H21NO5Cor e Forma:SolidPeso molecular:415.44A110
CAS:A110 is a potent and selective IMPDHs inhibitor. It binds to the NAD(+) cofactor site and forms a ternary complex with IMP.Fórmula:C19H15ClN4O2Pureza:98%Cor e Forma:SolidPeso molecular:366.8HIV-1 protease-IN-2
CAS:<p>HIV-1 protease-IN-2: strong HIV-1 protease blocker, IC50 2.53 nM, fights DRV-sensitive/resistant HIV-1.</p>Fórmula:C27H34N4O7SCor e Forma:SolidPeso molecular:558.65Antifungal agent 59
CAS:<p>Antifungal agent 59 exhibits potent activity, reflected by MIC values ranging from 0.01 to 1 μg/mL, and inhibits the formation of fungal biofilms, while</p>Fórmula:C18H15BrF2N2SeCor e Forma:SolidPeso molecular:456.19KDU731
CAS:KDU731: oral drug for Cryptosporidium-induced diarrhea, safe PI4K inhibitor (IC50: 25 nM), effective in vitro/in vivo.Fórmula:C22H16N6O2Pureza:98%Cor e Forma:SolidPeso molecular:396.4BPH-1218
CAS:BPH-1218 is a SQS inhibitor.Fórmula:C15H30N2O6P2Pureza:98%Cor e Forma:SolidPeso molecular:396.36pUL89 Endonuclease-IN-2
CAS:<p>pUL89 Endonuclease-IN-2 inhibits HCMV with a 3.0 μM IC50, showing potent antiviral effects.</p>Fórmula:C17H12F3N3O3SCor e Forma:SolidPeso molecular:395.36RyRs activator 1
CAS:<p>RyRs activator 1 triggers ranibulin receptors; 100% larvicidal at 0.5 mg/L, 90% at 0.01 mg/L.</p>Fórmula:C21H14ClF3N6O4Cor e Forma:SolidPeso molecular:506.825,10-Dideazaaminopterin
CAS:<p>5,10-Dideazaaminopterin is an antileukemic drug.</p>Fórmula:C21H22N6O5Pureza:98%Cor e Forma:SolidPeso molecular:438.44Triaziquone
CAS:<p>Triaziquone is an alkylating agent that can react with DNA to form intrastrand crosslinks.</p>Fórmula:C12H13N3O2Cor e Forma:SolidPeso molecular:231.25Cap-dependent endonuclease-IN-3
CAS:<p>Cap-dependent endonuclease-IN-3 inhibits CEN, promising for studying influenza A/B. (Patent WO2019141179A1, compound III-2)</p>Fórmula:C29H25F2N3O7SCor e Forma:SolidPeso molecular:597.59SDH-IN-5
CAS:<p>SDH-IN-5 (compound 7d), a potent inhibitor of succinate dehydrogenase (SDH) with an IC50 of 3.293 μM, additionally demonstrates antifungal efficacy, exhibiting</p>Fórmula:C16H19F2N3O2Cor e Forma:SolidPeso molecular:323.34(+)-Dihydrocalanolide A
CAS:<p>DHCal A (NSC 678323) is an oral nonnucleoside Reverse Transcriptase inhibitor for HIV research.</p>Fórmula:C22H28O5Cor e Forma:SolidPeso molecular:372.45HPV18-IN-1
CAS:<p>HPV18-IN-1, potent cervical cancer inhibitor, blocks E7-Rb-E2F pathway and DNA methylation.</p>Fórmula:C14H10N4OSCor e Forma:SolidPeso molecular:282.32RD3-0028
CAS:<p>RD3-0028 is a potent and selective RSV replication inhibitor(EC50 of 4.5 μM).</p>Fórmula:C8H8S2Pureza:98%Cor e Forma:SolidPeso molecular:168.28Abimtrelvir
CAS:<p>Abimtrelvir exhibited antiviral activity.</p>Fórmula:C24H17ClF3N7O2Cor e Forma:SolidPeso molecular:527.89Antimicrobial agent-5
<p>Antimicrobial agent-5: potent, selective for Gram-negative/positive bacteria, blocks LPS-CD14/TLR4, anti-inflammatory.</p>Fórmula:C32H48N16Cor e Forma:SolidPeso molecular:656.83RIG-1 modulator 1
CAS:RIG-1 modulator 1 is useful for the treatment of viral infections including influenza virus, HBV, HCV and HIV.Fórmula:C14H17N5OS2Pureza:98%Cor e Forma:SolidPeso molecular:335.45(S)-Enzaplatovir
CAS:<p>(S)-Enzaplatovir, an S-enantiomer with antiviral properties, has an EC50 of 56 nM against RSV.</p>Fórmula:C20H19N5O3Cor e Forma:SolidPeso molecular:377.4
